Digitally Reframing HealthTech: How Tabitha Howe Is Changing What You Know About Medical Innovation

In health technology, breakthroughs often begin in research labs and clinical trials. But turning complex science into something people understand and trust is an entirely different challenge.

For Tabitha Howe, Head Social Media Strategist at Flow Neuroscience, that challenge sits at the centre of her work. At a time when digital platforms increasingly shape how people discover and engage with healthcare innovation, Howe is leading a social strategy designed to make complex medical technology both accessible and meaningful to a global audience.

Flow Neuroscience develops a pioneering at-home treatment for depression, marking a significant step forward in the evolution of digital healthcare. The company’s headset delivers transcranial direct current stimulation (tDCS) and, as of 2025, became the first device of its kind to receive FDA approval as a non-drug treatment for depression, a major milestone in the medical technology landscape.

Communicating a breakthrough like this online requires a careful balance.

Unlike many sectors where social media marketing can rely on bold claims or fast moving trends, health tech exists within a tightly regulated environment. Messaging must remain medically accurate while also being sensitive to the realities of mental health, a topic that demands nuance, empathy and responsibility.

“It’s not just about promoting a product,” Howe explains. “You are translating complex science into something people can understand while respecting the seriousness of the subject. The goal is to build trust first and awareness second.”

Rather than approaching social media as a traditional marketing channel, Howe has developed a strategy rooted in education, transparency, and storytelling. Her content spans from demystifying the technology behind Flow and its role in treating depression to engaging broader conversations about mental health stigmas and healthcare innovation.

This approach has already begun to shift how audiences interact with the brand online. Over the past year, Flow’s social channels have seen significant growth across reach, engagement, and followers, with campaign views and audience interactions increasing by well over 100 percent as awareness around the technology continues to expand.

Since implementing her strategy, Flow’s social accounts have grown organically from zero to over 22,000 followers, demonstrating sustained audience interest in both the technology and the broader mental health conversations the company promotes.

For Howe, the focus has been less about chasing viral moments and more about building a sustained organic presence where innovation can be understood by the people it is designed to help.

The challenge of marketing a medical device with sensitive mental health applications requires a carefully calibrated approach. Howe has navigated complex regulatory restrictions while creating content that is approachable, educational, and relatable to everyday users.

“Health technology is evolving incredibly quickly,” she says. “But for many people, the science can feel intimidating or distant. Social media gives us a chance to bridge that gap and make these innovations feel accessible and relatable. The ability to communicate innovation clearly and responsibly is becoming just as important as the breakthroughs themselves.”

Howe’s innovative approach is also influencing the broader industry. Her strategy demonstrates how health tech companies can leverage digital channels responsibly to educate and engage audiences, setting a benchmark for others in the space who are seeking to communicate complex medical innovation without compromising accuracy or sensitivity.

For companies working at the frontier of medical science, awareness is no longer built purely through clinical validation or traditional media coverage. Increasingly, it is shaped through digital conversations that translate complex ideas into everyday understanding.

At Flow Neuroscience, Howe’s work sits at the intersection of science, storytelling, and digital strategy. By building a social presence that prioritises transparency, education, and community engagement, she is redefining how emerging medical technologies connect with the public and their target audiences.

The impact has not gone unnoticed. As the digital health sector continues to expand, more companies are beginning to recognise the importance of thoughtful and responsible social media communication that Howe has built at Flow.

“We are already seeing other health tech companies pay closer attention to how the space is evolving online,” Howe says. “There is a growing recognition that communicating medical innovation requires a completely different approach to traditional marketing.”

For Howe, helping lead this shift is both challenging and deeply rewarding.

“Ultimately, innovation only matters if people understand it,” she says. “One of the most exciting parts of working in this space is helping bring those breakthroughs out of the lab and into conversations people can actually engage with.”

As the health tech sector continues to evolve, Howe believes the companies that succeed will be those able to translate cutting edge science into understanding that truly resonates with people. Through her work shaping Flow Neuroscience’s social presence, she is among the few leading the transformation of digital communication in medical innovation.